c-Met inhibition enhances chemosensitivity of human ovarian cancer cells

A Time to Kill: Targeting Apoptosis in Cancer

(2015) Jean Koff et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to Bedside

(2014) A. Furlan et al.   CANCER RESEARCH

Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress

(2014) Sharareh Gholamin et al.   CURRENT DRUG TARGETS

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

(2014) Shigehiro Yagishita et al.   CURRENT DRUG TARGETS

Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met

(2014) E. Giovannetti et al.   CURRENT DRUG TARGETS

Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells

(2014) Xinmei Wang et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Analysis of MET mRNA Expression in Gastric Cancers Using RNA In Situ Hybridization Assay: Its Clinical Implication and Comparison with Immunohistochemistry and Silver In Situ Hybridization

(2014) Jiwoon Choi et al.   PLoS One

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

(2014) Zhijie Wang et al.   PLoS One

Molecular Targets in the Treatment of Non—Small-Cell Lung Cancer: Is There Hope on the Horizon?

(2014) Corey A. Carter et al.   POSTGRADUATE MEDICINE

Epithelial Ovarian Cancer-Induced Angiogenic Phenotype of Human Omental Microvascular Endothelial Cells May Occur Independently of VEGF Signaling

(2014) Boleslaw K. Winiarski et al.   Translational Oncology

Insights into the Mechanism of Organ-Specific Cancer Metastasis

(2014) M. A. Rubin   Cancer Discovery

Spontaneous Peripheral T-cell Responses toward the Tumor-Associated Antigen Cyclin D1 in Patients with Clear Cell Renal Cell Carcinoma

(2013) S. R. Dannenmann et al.   Cancer Immunology Research